Gastroenterology

Advantages of an Oral Aptamer

Oral administration of highly stable, non-absorbed inhibitor aptamer will:

Provide a local effect on GI mucosa

With a very patient-friendly dosing regimen…

While avoiding systemic immunosuppression and thrombosis-related risks

Guardian’s Aptamers Remain Intact Even Under Conditions of the GI Tract

Incubated in simulated gastric fluids

Assayed for full-length, intact, aptamer

Virtually 100% preserved for full duration of incubation

Fully 2’OMethyl Aptamer Passes Intact Through Entire Length of GI Tract

Fully 2’OMethyl aptamer assayed in mass balance study

  • POC with naked VWF aptamer (BT100) and VWF aptamer w/40KDa PEG (BT200)

  • HPLC-FL method used for full-length, intact aptamer detection with high sensitivity

  • ~20% total naked aptamer dose recovered in feces

  • Fecal concentration is 50,000-fold higher than plasma Cmax

  • Fecal recovery is probably underestimated, as the fecal extraction method has not yet been optimized

  • ~40% total PEGylated aptamer dose recovered in feces

  • Zero detected in plasma

Contact

© 2023 Guardian Therapeutics. All rights reserved.

Welcome to the Guardian Therapeutics and Band Therapeutics website. We do not use any cookies or other technologies on this website, except those that are strictly necessary to enable normal functioning of this web page. View our data protection statement.

Headquarters
Guardian Therapeutics
101 Hartwell Avenue
Suite 2
Lexington, MA 02421
+1 (781) 918-6580

General Inquiries:
info@guardian-rx.com

Business Development Inquiries: businessdevelopment@guardian-rx.com